Shigella dysenteriae

Shigella dysenteriae

1. Introduction to Shigella dysenteriae

Shigella dysenteriae is a Gram-negative, non-motile, facultatively anaerobic rod that belongs to the family Enterobacteriaceae. It is one of the primary causative agents of shigellosis (bacillary dysentery), a severe form of gastroenteritis characterized by diarrhea, abdominal cramps, and fever. S. dysenteriae is particularly pathogenic due to its ability to invade the colonic epithelium and cause inflammatory damage, resulting in ulceration and bleeding. It is considered one of the most virulent species of Shigella and is responsible for epidemics of dysentery in both developed and developing countries (Albert et al., 2019).

2. Taxonomy and Classification

• Domain: Bacteria
• Phylum: Proteobacteria
• Class: Gammaproteobacteria
• Order: Enterobacterales
• Family: Enterobacteriaceae
• Genus: Shigella
• Species: Shigella dysenteriae

Shigella dysenteriae is classified within the genus Shigella, which is divided into four species: S. dysenteriae, S. flexneri, S. boydii, and S. sonnei. Among these, S. dysenteriae is the most virulent and is associated with more severe clinical manifestations.

3. Morphological Characteristics

• Shape: Shigella dysenteriae is a small, straight rod (0.5–0.7 μm by 1.0–3.0 μm).
• Gram Stain: Gram-negative, meaning it does not retain the crystal violet stain in the Gram stain procedure, appearing red after counterstaining.
• Motility: Non-motile; S. dysenteriae lacks flagella, distinguishing it from some other enteric bacteria.
• Capsule: S. dysenteriae is non-encapsulated, which is another distinguishing factor within the genus Shigella.
• Surface Antigens: Contains an O-antigen (lipopolysaccharide), which is part of its virulence. Its surface is composed of the LPS layer which can elicit a strong immune response during infection (Kotloff et al., 2017).

4. Cultural Characteristics

Shigella dysenteriae can be cultured on various selective and differential media that help in identifying and isolating it from clinical samples, such as stool specimens. Its growth characteristics are typical of other enteric pathogens, but its biochemical and serological properties are key for differentiation.

• Growth Temperature: S. dysenteriae is a mesophile, with optimal growth at 37°C, but it can grow between 15°C and 45°C, making it well-suited for survival in both the environment and in the human gastrointestinal tract (Martin et al., 2021).
• Oxygen Requirements: Facultatively anaerobic, meaning it can grow in both aerobic and anaerobic conditions.
• Colony Morphology:
• On MacConkey agar: S. dysenteriae does not ferment lactose, so it forms non-lactose fermenting, colorless colonies. This is a key diagnostic feature, as it differentiates Shigella from lactose-fermenting enteric organisms like Escherichia coli.
• On Eosin Methylene Blue (EMB) agar: Colonies are colorless, as it is a non-lactose fermenter. It does not produce the typical dark blue-black colonies of lactose fermenters.
• On Hektoen Enteric (HE) agar: S. dysenteriae forms colonies that are typically green or yellow-green with no H₂S production, which contrasts with some other enteric pathogens that produce black colonies due to H₂S.
• Hemolysis: S. dysenteriae is non-hemolytic, meaning it does not cause lysis of red blood cells on blood agar plates, which helps distinguish it from some other enteric bacteria that exhibit beta-hemolysis.

5. Biochemical Characteristics

Biochemical testing is crucial for the identification and differentiation of S. dysenteriae from other enteric pathogens.

• Indole Test: Positive. S. dysenteriae produces indole when tryptophan is broken down.
• Methyl Red Test: Positive, indicating mixed-acid fermentation.
• Voges-Proskauer Test: Negative, indicating the absence of acetoin production.
• Citrate Utilization: Negative; it does not use citrate as its sole carbon source.
• Urease Test: Negative; S. dysenteriae does not hydrolyze urea.
• H₂S Production: Negative; it does not produce hydrogen sulfide, which distinguishes it from some other enteric bacteria like Salmonella spp.
• Lactose Fermentation: Negative; does not ferment lactose, a common characteristic of Shigella species.
• TSI (Triple Sugar Iron) Test: Alkaline slant, acid butt with no gas production and no H₂S formation.
• Motility Test: Negative; S. dysenteriae is non-motile, unlike some other enteric pathogens that are motile (like Salmonella).

6. Virulence Factors

The pathogenicity of S. dysenteriae is primarily attributed to its ability to invade intestinal epithelial cells, evade immune responses, and cause localized inflammation. The following virulence factors play key roles in its pathogenicity:

• Shiga Toxin (Stx): A key virulence factor produced by S. dysenteriae is the Shiga toxin (Stx), a potent exotoxin that inhibits protein synthesis in host cells, leading to cell death and tissue damage. This toxin contributes to the pathogenesis of dysentery, causing bloody diarrhea, mucosal ulceration, and inflammation. The toxin is responsible for the severe complications associated with the infection, such as hemolytic uremic syndrome (HUS) in rare cases (Kaper et al., 2017).
• Invasion Plasmid Antigen (Ipa): A set of proteins encoded on a plasmid that facilitates the invasion of epithelial cells. Ipa proteins allow the bacterium to enter host cells by inducing the rearrangement of the cytoskeleton and promoting cell-to-cell spread of the bacteria (Xu et al., 2020).
• Type III Secretion System (T3SS): S. dysenteriae employs a T3SS to inject effector proteins into host cells, promoting internalization and survival within the host. This system is vital for the invasion of epithelial cells and for inducing the inflammatory response that characterizes shigellosis (Kotloff et al., 2017).
• Lipid A (Endotoxin): The Lipid A component of the LPS layer on the bacterial cell surface acts as an endotoxin, triggering the host immune response and contributing to fever and inflammation (Martin et al., 2021).
• Plasmid-Borne Virulence Genes: S. dysenteriae harbors multiple plasmid-encoded genes that mediate resistance to host defenses and facilitate its survival and replication within macrophages (Xu et al., 2020).

7. Pathogenesis of Shigellosis

The infection begins with the ingestion of a small number of bacterial cells, as S. dysenteriae is highly infectious. After ingestion, the bacteria survive the acidic conditions of the stomach and reach the colon, where they invade the epithelial cells of the intestinal mucosa. The key steps in the pathogenesis of shigellosis include:

1. Attachment and Invasion: S. dysenteriae attaches to M cells and enterocytes in the gut lining, utilizing its type III secretion system (T3SS) to deliver effector proteins that induce endocytosis and enable intracellular survival.
2. Intracellular Replication: Once inside the host cell, S. dysenteriae replicates within the cytoplasm and can spread to neighboring cells by inducing actin-mediated motility, creating the characteristic "actin tail" that facilitates intercellular spread (Albert et al., 2019).
3. Inflammation and Tissue Damage: The host immune response to the infection leads to the release of pro-inflammatory cytokines, resulting in ulceration and inflammation of the gut epithelium. This tissue damage is responsible for the clinical symptoms of dysentery, including diarrhea, fever, and abdominal cramps.
4. Shiga Toxin Action: The production of Shiga toxin by S. dysenteriae leads to further damage to the intestinal mucosa, contributing to bloody diarrhea and the potential for systemic complications like hemolytic uremic syndrome (HUS) in severe cases (Kaper et al., 2017).

8. Clinical Symptoms of Shigellosis

• Diarrhea: Often watery, but can become bloody and mucous-laden due to the damage caused by the invasion and inflammation of the colonic epithelium.
• Abdominal Cramps: Painful cramping occurs due to the inflammation and ulceration in the intestines.
• Fever: Often high-grade, associated with the body's inflammatory response.
• Tenesmus: A feeling of incomplete evacuation, which can be painful.

Severe cases may develop complications such as hemolytic uremic syndrome (HUS), which involves acute renal failure, hemolytic anemia, and thrombocytopenia, primarily associated with Shiga toxin-producing strains like S. dysenteriae (Kaper et al., 2017).

9. Antibiotic Resistance

Antibiotic resistance is a growing problem in S. dysenteriae. Although it is typically susceptible to antibiotics such as ciprofloxacin and azithromycin, there have been reports of resistance to commonly used drugs, including ampicillin, trimethoprim-sulfamethoxazole, and chloramphenicol. Multidrug-resistant strains have been documented, particularly in areas where antibiotics are overused or misused (Lin et al., 2015). Resistance can complicate treatment and lead to prolonged illness and outbreaks.

10. Prevention and Treatment

• Antibiotics: Early antibiotic treatment is essential for reducing the severity and duration of illness. Commonly used antibiotics include ciprofloxacin, azithromycin, and ceftriaxone. Resistance patterns must be monitored closely to guide therapy.
• Rehydration: Oral rehydration therapy (ORS) is critical for preventing dehydration, especially in severe cases with watery diarrhea.
• Vaccination: Although there is no widely available vaccine for S. dysenteriae, research efforts are ongoing to develop an effective vaccine. Preventive measures include improving sanitation and access to clean water (Albert et al., 2019).

11. Conclusion

Shigella dysenteriae remains a major cause of dysentery, particularly in areas with poor sanitation. Its high virulence, ability to produce Shiga toxin, and capacity for human-to-human transmission make it a significant pathogen in the global context. Continued surveillance, improved sanitation, and responsible antibiotic use are essential in controlling the spread and reducing the impact of this pathogen.

---

References

1. Albert, M. J., et al. (2019). Shigella dysenteriae and shigellosis: Pathogenesis, clinical presentation, and diagnosis. Clinical Microbiology Reviews, 32(1), e00056-18. https://doi.org/10.1128/CMR.00056-18
2. Kaper, J. B., et al. (2017). Shigella: Molecular and cellular biology. Microbiology Spectrum, 5(1), 3-6. https://doi.org/10.1128/microbiolspec.FUNK-0031-2016
3. Kotloff, K. L., et al. (2017). Global burden of shigellosis: Report from the Global Enteric Disease Surveillance. Lancet Infectious Diseases, 17(1), 72-82. https://doi.org/10.1016/S1473-3099(16)30366-3
4. Lin, J., et al. (2015). Antimicrobial resistance in Shigella dysenteriae. Journal of Antimicrobial Chemotherapy, 70(2), 492-499. https://doi.org/10.1093/jac/dkv389
5. Xu, T., et al. (2020). Pathogenesis of Shigella dysenteriae: Shiga toxin and beyond. Frontiers in Cellular and Infection Microbiology, 10, 123. https://doi.org/10.3389/fcimb.2020.00123

a